Agoracom: Small Cap Investment - Resverlogix Corp.

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Reply New Message

Back To Forum List View

May 04, 2016 11:39AM

May 24, 2016 11:04AM

Jun 07, 2016 05:54PM

Jun 29, 2016 11:25AM

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: ESPR

posted on Jul 07, 2016 10:17AM

Yes there is value in pursuing LDL lowering. Especially in the crowd that cannot tolerate statins. The ongoing CVOT trials for the anti-PCSK9 antibody therapies will further bolster the contribution of LDL to cardiovascular disease, if successful. LDL and HDL are both still regarded as independent contributors to cardiovascular disease.